Previous Close | 6.00 |
Open | 6.00 |
Bid | 7.00 |
Ask | 7.20 |
Strike | 10.00 |
Expire Date | 2024-12-20 |
Day's Range | 6.00 - 6.00 |
Contract Range | N/A |
Volume | |
Open Interest | N/A |
The genetic testing firm will also close its therapeutics arm. CEO Anne Wojcicki said the cuts are necessary to “focus on the long-term success of our core consumer business.”
Despite a revenue decline, 23andMe Holding Co (ME) focuses on cost-saving measures and recurring revenue growth to enhance financial stability.